Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
596
144
148
158
143
143
Revenue Growth (YoY)
-6%
1%
1%
-7%
-17%
-10%
Cost of Revenue
334
82
84
90
76
77
Gross Profit
261
62
63
67
67
65
Selling, General & Admin
245
67
60
55
61
71
Research & Development
35
9
9
10
6
6
Operating Expenses
281
77
69
66
67
78
Other Non Operating Income (Expenses)
2
4
0
0
0
1
Pretax Income
-150
-157
-2
5
3
-10
Income Tax Expense
-40
0
3
-45
2
7
Net Income
-178
-160
-15
50
-52
-40
Net Income Growth
174%
300%
15%
-1,350%
767%
-71%
Shares Outstanding (Diluted)
46.06
46.06
45.92
45.83
45.82
45.73
Shares Change (YoY)
1%
1%
1%
-4%
-13%
-18%
EPS (Diluted)
-3.86
-3.49
-0.33
1.12
-1.15
-0.88
EPS Growth
172%
297%
14%
-1,179%
825%
-64%
Free Cash Flow
30
6
14
-5
14
6
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
43.79%
43.05%
42.56%
42.4%
46.85%
45.45%
Operating Margin
-3.18%
-10.41%
-4.05%
0.63%
0%
-8.39%
Profit Margin
-29.86%
-111.11%
-10.13%
31.64%
-36.36%
-27.97%
Free Cash Flow Margin
5.03%
4.16%
9.45%
-3.16%
9.79%
4.19%
EBITDA
37
-1
7
15
14
1
EBITDA Margin
6.2%
-0.69%
4.72%
9.49%
9.79%
0.69%
D&A For EBITDA
56
14
13
14
14
13
EBIT
-19
-15
-6
1
0
-12
EBIT Margin
-3.18%
-10.41%
-4.05%
0.63%
0%
-8.39%
Effective Tax Rate
26.66%
0%
-150%
-900%
66.66%
-70%
Follow-Up Questions
What are Azenta Inc's key financial statements?
According to the latest financial statement (Form-10K), Azenta Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for AZTA?
Azenta Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Azenta Inc's revenue broken down by segment or geography?
Azenta Inc largest revenue segment is Multiomics, at a revenue of 269,231,000 in the most earnings release.For geography, North America is the primary market for Azenta Inc, at a revenue of 323,982,000.
Is Azenta Inc profitable?
no, according to the latest financial statements, Azenta Inc has a net loss of $0